Clinical Trial

Effects of Metformin During Nicotine Withdrawal

Study Description

Effects of Metformin During Nicotine Withdrawal

The purpose of this study is to test the effects of a medication called metformin (GlucophageAR) on smoking behavior. This medication is FDA-approved for treatment of type-2 diabetes. It is being used for research purposes in this study. Participants will be randomized to one of 3 treatment groups: low dose of metformin, high dose of metformin, or placebo.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Metformin

Metformin capsule

Drug - Placebo

Sucrose filler in gel capsules

Additional Information

Official Study Title

Effects of Metformin on Mood and Cognition During Nicotine Withdrawal

Clinical Trial ID

NCT03593538

ParticipAid ID

bmZZ9d